Preparation and evaluation of injectable Rasagiline mesylate dual-controlled drug delivery system for the treatment of Parkinson's disease

• Prif Awduron: Ying Jiang (Awdur), Xuemei Zhang (Awdur), Hongjie Mu (Awdur), Hongchen Hua (Awdur), Dongyu Duan (Awdur), Xiuju Yan (Awdur), Yiyun Wang (Awdur), Qingqing Meng (Awdur), Xiaoyan Lu (Awdur), Aiping Wang (Awdur), Wanhui Liu (Awdur), Youxin Li (Awdur), Kaoxiang Sun (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Taylor & Francis Group, 2018-01-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

A microsphere-gel in situ forming implant (MS-Gel ISFI) dual-controlled drug delivery system was applied to a high water-soluble small-molecule compound Rasagiline mesylate (RM) for effective treatment of Parkinson's disease. This injectable complex depot system combined an in situ phase transi...